Illinois Retina Associates is a prominent player in the Health Care industry, with a history dating back to 1976. The organization prioritizes the diagnosis and treatment of diseases affecting the retina, macula, and vitreous, showcasing expertise in managing conditions such as diabetic retinopathy, macular degeneration, vascular occlusive diseases, and uveitis. Notably, the company has actively contributed to numerous studies conducted by esteemed institutions like the National Institutes of Health (NIH), the National Eye Institute (NEI), and the Food and Drug Administration. Although specific details regarding their last investment and associated investors are not available at this time, Illinois Retina Associates' commitment to advancing treatments and understanding in the field of retinal health positions them as an intriguing prospect for potential venture capital consideration.
There is no investment information
No recent news or press coverage available for Illinois Retina Associates.
We care about your data, and we'd love to use cookies make your experience better.
